Mas, S
Gassó, P
Lafuente, A
Bioque, M
Lobo, A
Gonzàlez-Pinto, A
Olmeda, M S
Corripio, I
Llerena, A
Cabrera, B
Saiz-Ruiz, J
Bernardo, M
Mezquida, Gisela
Meseguer, Ana
Bernardo, Enrique García
Parellada, Mara
Alonso-Solís, Anna
Grasa, Eva
Hernandez, Miryam
Cengotitabengoa, Monica Martinez
Barcones, Fe
Arbej, Julio
Sanjuan, Julio
Aguilar, Eduardo J
Balbuena, Antonio
Mané, Anna
Torrent, Carla
Vieta, Eduard
Baeza, Immaculada
Serna, Elena de la
Contreras, Fernando
Albacete, Auria
García-Portilla, Maria Paz
Bobes, Julio
Zabala Rabadán, Arantzazu
Segarra Echevarría, Rafael
Morales-Muñoz, Isabel
Rodriguez-Jimenez, Roberto
Butjosa, Anna
Usall Rodie, Judith
Sarró, Salvador
Landín-Romero, Ramón
Ibañez Cuadrado, Angela
Cuesta, Manuel J
Balanzá-Martínez, Vicent
,
Article History
Received: 30 November 2015
Revised: 22 April 2016
Accepted: 2 May 2016
First Online: 7 June 2016
Competing interests
: AA has received a trainee research staff grant awarded by the University of Barcelona (APIF-UB grants). AB has received grants from the Spanish Ministry of Science and Innovation (FIS). AL has received grants from the Spanish Ministry of Science and Innovation (FIS). AM has received financial support to attend meetings, travel support and served as a speaker from Otsuka and Janssen-Cilag. EV has received grants and served as consultant, advisor or CME speaker for the following entities: AstraZeneca, Bristol-Myers Squibb, Ferrari, Forest Research Institute, Gideon Richter, GlaxoSmithKline, Janssen, Lundbeck, Otsuka, Pfizer, Roche, Snafu-Aventis, Servier, Shire, Sunovion, Takeda, the Brain and Behaviour Foundation, the Spanish Ministry of Science and Innovation (CIBERSAM), the Seventh European Framework Programme (ENBREC) and the Stanley Medical Research Institute. FC has received financial support to attend meetings, travel support and served as advisor or speaker for the following entities: Lilly, Janssen-Cilag, Lundbeck, Otsuka, the Spanish Ministry of Science and Innovation (CIBERSAM) and the Ministry of Science (Carlos III Institute). IB has received grants from CIBERSAM, Fundación Alicia Koplowitz and Institute de Salad Carlos III, and has received honoraria as a speaker for Janssen, as well as support from Otsuka for attending some conferences. MB has been a consultant for, received grant/research support and honoraria from, and been on the speakers/advisory board of ABBiotics, Adamed, Almirall, AMGEN, Eli Lilly, Ferrari, Forum Pharmaceuticals, Gideon, Hersill, Janssen-Cilag, Lundbeck, Otsuka, Pfizer, Roche and Servier, and has obtained research funding from the Spanish Ministry of Health, the Spanish Ministry of Science and Education, the Spanish Ministry of Economy and Competitiveness, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), by the Government of Catalonia, Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and the 7th Framework Program of the European Union. MB has been a consultant for, received grant/research support and honoraria from, and been on the speakers/advisory board of Adamed, Ferrer, Janssen-Cilag, Lundbeck, Otsuka and Pfizer. The remaining authors declare no conflict of interest.